65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04638517 (ClinicalTrials.gov)	September 7, 2021	4/11/2020	The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Im ...	The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Im ...	Telomere Shortening;Telomere Disease;Dyskeratosis Congenita;Pulmonary Fibrosis	Drug: Danazol;Drug: Placebo	The University of Queensland	NULL	Recruiting	5 Years	N/A	All	50	Phase 2	Australia
2	NCT01001598 (ClinicalTrials.gov)	November 2009	22/10/2009	Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita	Phase I/II Dose Escalation Trial of Danazolin Patients With Fanconi Anemia or Dyskeratosis Congenita ...	Fanconi Anemia;Dyskeratosis Congenita	Drug: danazol	Boston Children's Hospital	NULL	Terminated	3 Years	N/A	All	5	Phase 1/Phase 2	United States

First Previous1Next Last